Statistics
Publications
54
Citations
3.3K
H-Index
35
Active since
1979
Robert Hamatake is an author at GlaxoSmithKline (United States) specializing in life sciences, virology, and molecular biology.
Publications per year
1979–2021
54
54
RDEA119/BAY 869766: A Potent, Selective, Allosteric Inhibitor of MEK1/2 for the Treatment of Cancer
Cory Iverson, Gary Larson, Chon Lai et al. · Cancer Research · 2009 · 183 citations · Full text
Medicine, Oncology, Pharmacology +17
Robert Hamatake, Hiromasa Hasegawa, Allan Clark et al. · Journal of Biological Chemistry · 1990 · 148 citations · Full text
1–5 of 54